Avanafil for male erectile dysfunction: a systematic review and meta-analysis

Avanafil, a potent new selective phosphodiesterase type 5 (PDE5) inhibitor, has been developed for the treatment of erectile dysfunction (ED). We carried out a systematic review and meta-analysis to assess the efficacy and safety of this drug for the treatment of ED. A literature review was performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yuan-Shan, Li, Nan, Zong, Huan-Tao, Yan, Hui-Lei, Zhang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023381/
https://www.ncbi.nlm.nih.gov/pubmed/24589460
http://dx.doi.org/10.4103/1008-682X.123670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023381/
https://www.ncbi.nlm.nih.gov/pubmed/24589460
http://dx.doi.org/10.4103/1008-682X.123670

Ejemplares similares